ES2024010B3 - Unidad de dosis farmaceutica. - Google Patents

Unidad de dosis farmaceutica.

Info

Publication number
ES2024010B3
ES2024010B3 ES88201240T ES88201240T ES2024010B3 ES 2024010 B3 ES2024010 B3 ES 2024010B3 ES 88201240 T ES88201240 T ES 88201240T ES 88201240 T ES88201240 T ES 88201240T ES 2024010 B3 ES2024010 B3 ES 2024010B3
Authority
ES
Spain
Prior art keywords
dose unit
pharmaceutical dose
pharmaceutical
preventing
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88201240T
Other languages
English (en)
Inventor
Lambert Joseph Wilhelm Marie Tax
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Application granted granted Critical
Publication of ES2024010B3 publication Critical patent/ES2024010B3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
ES88201240T 1987-07-06 1988-06-20 Unidad de dosis farmaceutica. Expired - Lifetime ES2024010B3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8701586 1987-07-06

Publications (1)

Publication Number Publication Date
ES2024010B3 true ES2024010B3 (es) 1992-02-16

Family

ID=19850262

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88201240T Expired - Lifetime ES2024010B3 (es) 1987-07-06 1988-06-20 Unidad de dosis farmaceutica.

Country Status (12)

Country Link
US (1) US4914089A (es)
EP (1) EP0300523B1 (es)
JP (1) JPS6429314A (es)
KR (1) KR950010156B1 (es)
AT (1) ATE66149T1 (es)
AU (1) AU611168B2 (es)
CA (1) CA1313622C (es)
DE (1) DE3864210D1 (es)
DK (1) DK376188A (es)
ES (1) ES2024010B3 (es)
GR (1) GR3003104T3 (es)
ZA (1) ZA884418B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
EP0496520A1 (en) * 1991-01-22 1992-07-29 Merck & Co. Inc. Novel bone acting agents
ES2123666T3 (es) * 1992-03-21 1999-01-16 Entec Aplicacion de estriol para la preparacion de un sistema terapeutico transdermico para tratar la osteoporosis climaterica.
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
IL113816A (en) 1994-06-08 1998-12-06 Akzo Nobel Nv Pharmaceutical compositions containing desogestrel their preparation and use
IL128818A0 (en) * 1998-03-12 2000-01-31 Akzo Nobel Nv Making dosage units using low shear granulation
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
EP1622623A4 (en) * 2003-04-11 2009-03-18 Barr Lab Inc METHOD FOR THE ADMINISTRATION OF ESTROGENIC AND TESTED
US20060183724A1 (en) * 2005-02-03 2006-08-17 Diliberti Charles E Compositions of unconjugated estrogens and methods for their use
USD731568S1 (en) * 2013-08-01 2015-06-09 Sejong Pharmatech Co., Ltd. Compression molding machine for tablets
USD741386S1 (en) * 2013-09-13 2015-10-20 Carefusion Germany 326 Gmbh Machine for packaging dosed quantities of solid drug portions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6615481A (es) * 1966-11-02 1968-05-03
DE2645307A1 (de) * 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
AU582540B2 (en) * 1983-08-05 1989-04-06 Pre Jay Holdings Ltd. A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
GB8617560D0 (en) * 1986-07-18 1986-08-28 Raychem Gmbh Cable connector

Also Published As

Publication number Publication date
DK376188A (da) 1989-01-07
DE3864210D1 (de) 1991-09-19
GR3003104T3 (en) 1993-02-17
DK376188D0 (da) 1988-07-06
JPS6429314A (en) 1989-01-31
EP0300523B1 (en) 1991-08-14
CA1313622C (en) 1993-02-16
KR890001564A (ko) 1989-03-27
AU1866888A (en) 1989-01-12
EP0300523A1 (en) 1989-01-25
ZA884418B (en) 1990-02-28
AU611168B2 (en) 1991-06-06
ATE66149T1 (de) 1991-08-15
KR950010156B1 (en) 1995-09-11
US4914089A (en) 1990-04-03

Similar Documents

Publication Publication Date Title
ES2024010B3 (es) Unidad de dosis farmaceutica.
IT8619625A0 (it) Composizioni farmaceutiche per inalazione.
FI883750L (fi) Transdermal plaoster foer administrering av ett laekemedel.
DK393187A (da) Laegemiddel med antitumorvirkning
FI881177A0 (fi) Anordning foer positionering av en patient i en medicinsk panoramaroentgenfotograferingsanordning.
NL188501C (nl) Harsachtige samenstelling voor een tandheelkundige toepassing.
DK0432117T3 (da) Farmaceutisk præparat til behandling af inflammation
FI913608A7 (fi) Annosmuoto kalsiumantagonistin annostelemiseksi
IT8820751A0 (it) Apparecchio per la correzione delle malposizioni dentarie.
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
NO910869L (no) Fremgangsmaate for desinfeksjon av medisinsk avstoepningsmasse.
DK0511799T3 (da) Farmaceutiske forbindelser
ATE59550T1 (de) Chlorpheniramine therapie.
FI881435A7 (fi) Hammaslääketieteellinen röntgenlaite
SE9003902D0 (sv) Solid dosage forms of a drug
DK256689D0 (da) 1,2-dithiol-3-thion-s-oxid-forbindelser til anven delse som laegemidler
FI824170A7 (fi) Imidatsobensodiatsepiinit, menetelmä niiden valmistamiseksi, näitä yhdisteitä sisältävät farmaseuttiset valvalmisteet ja niiden terapeuttinen käyttö.
FI930097A7 (fi) Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten
NO892006D0 (no) Anordning for dannelse av oppstaaende kant.
IT8125670A0 (it) Poltrona odontoiatrica per paziente.
RO81783A3 (ro) Medicament pentru tratamentul maladiei neoplazice
ES2101982T3 (es) Composicion conteniendo una alta dosis de vitamina a.
IT8324018V0 (it) Siringa porta-amalgama per otturazioni canalari per via retrograda per cure dentarie.
IT8523530V0 (it) Dispositivo perfezionato per somministrazione medicinali iniettabili.
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments